Minhaj Akhtar Usmani,
Kainat Akhtar Usmani,
- Associate Professor, Department of Food and Nutrition, Era University, Lucknow, Uttar Pradesh, India
- Assistant Professor, Department of Commerce and Business Management, Integral University, Lucknow, Uttar Pradesh, India
Abstract
Cannabinoids, the bioactive compounds derived from the Cannabis sativa plant, have garnered increasing interest for their potential role as nutritional supplements. This abstract provides a succinct overview of cannabinoids as nutritional supplements. This review delves into the multifaceted aspects of cannabinoids, particularly their interaction with the endocannabinoid system (ECS) and their potential health benefits. The exploration begins by elucidating the intricate relationship between cannabinoids and the ECS, a vital regulatory system in the human body responsible for maintaining homeostasis. The review examines the potential health benefits associated with cannabinoids as nutritional supplements, including anti-inflammatory properties, stress and anxiety reduction, appetite regulation, and potential neuroprotective effects. Safety considerations take center stage, addressing the importance of quality and purity in cannabinoid-based products. The paper emphasizes the necessity for rigorous testing and standardized dosing recommendations, considering individual variability and potential adverse effects. Furthermore, it underscores the evolving regulatory landscape, discussing the global legal status of cannabinoids and the challenges posed by varying regulations. Further research on them as dietary supplements is needed to better understand the medical potential and safety of cannabis. Ongoing studies should focus on elucidating specific mechanisms of action within the ECS and exploring additional health benefits beyond those currently identified. As regulatory frameworks adapt globally, ensuring standardized production methods and clear labeling will be pivotal in promoting consumer trust and safety. Continued collaboration between researchers, regulators, and industry stakeholders is crucial for harnessing the benefits of cannabinoids while mitigating potential risks. Ultimately, this evolving field holds promise for novel therapeutic interventions, provided that scientific rigor and responsible oversight remain paramount. In conclusion, the paper highlights the dynamic nature of cannabinoids as a burgeoning field of research with promising implications for human health. As regulatory frameworks evolve, there is a need to strike a balance between guaranteeing consumer protection and providing access. The exploration of cannabinoids as nutritional supplements represents a multidimensional journey that necessitates continued research, responsible regulation, and informed consumer choices for the realization of their full potential.
Keywords: Cannabinoids, Cannabis sativa, anti-inflammatory properties, nutritional supplements
[This article belongs to Emerging Trends in Metabolites ]
Minhaj Akhtar Usmani, Kainat Akhtar Usmani. Cannabinoids as Nutritional Supplements: Exploring The Potential Health Benefits and Regulatory Landscape. Emerging Trends in Metabolites. 2024; 01(01):48-53.
Minhaj Akhtar Usmani, Kainat Akhtar Usmani. Cannabinoids as Nutritional Supplements: Exploring The Potential Health Benefits and Regulatory Landscape. Emerging Trends in Metabolites. 2024; 01(01):48-53. Available from: https://journals.stmjournals.com/etm/article=2024/view=152228
References
- Walker LA, Koturbash I, Kingston R, ElSohly MA, Yates CR, Gurley BJ, Khan I. Cannabidiol (CBD) in dietary supplements: perspectives on science, safety, and potential regulatory approaches. J Diet Suppl. 2020;17(5):493–502. doi:10.1080/19390211.2020.1777244.
- Koob GF, Arends MA, Le Moal M. Cannabinoids. In: Koob GF, Arends MA, Le Moal M, editors. Drugs, Addiction, and the Brain. Cambridge (MA): Academic Press; 2014. 261–308.
- Kaiser S, Monte A. Management of Cannabinoid Hyperemesis Syndrome—is it More than Just Avoiding Cannabis Use? In: Hasler WL, Levinthal DJ, Venkatesan T, editors. Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis. Cambridge (MA): Academic Press; 2022. 217–239. doi:10.1016/B978-0-12-821597-5.00002-2.
- Harry GJ. Chapter One – Cannabinoids. In: Slikker W, Aschner M, Costa LG, editors. Advances in Neurotoxicology. Cambridge (MA): Academic Press; 2022;8. 1–48. doi:10.1016/bs.ant.2022.06.001.
- Chilakapati J, Mehendale HM. Cannabinoids. In: Wexler P, editor. Encyclopedia of Toxicology. 2nd edition. Amsterdam: Elsevier; 2005. 405–407. doi:10.1016/B0-12-369400-0/00175-7.
- Bagshaw SM, Hagen NA. Medical efficacy of cannabinoids and marijuana: a comprehensive review of the literature. J Palliat Care. 2002;18(2):111–122. doi:10.1177/082585970201800207.
- Carter GT, Ugalde V. Medical marijuana: emerging applications for the management of neurologic disorders. Phys Med Rehabil Clin. 2004;15(4):943–954. doi:10.1016/j.pmr.2004.03.005.
- Leizer C, Ribnicky D, Poulev A, Stankov S, Raskin I. The composition of hemp seed oil and its potential as an important source of nutrition. J Nutraceuticals Funct Med Foods. 2000;2(4):35–53. doi:10.1300/J133v02n04_04.
- gov.au. (2024). Medicinal Cannabis [Online]. Health Direct. Available from: https://www.healthdirect.gov.au/medicinal-cannabis.
- com. (2016). Therapeutic effects and indications for Cannabis use [Online]. A Train Education. Available from: https://www.atrainceu.com/content/5-therapeutic-effects-and-indications-cannabis-use.
- nih.gov. (2018). Cannabis (Marijuana) and Cannabinoids: what you need to know [Online]. National Center for Complementary and Intergrative Health. Available from: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know.
- Preedy VR. Peroxisome Proliferator Activated Receptors and Cannabinoids. In: Preedy VR, editor. Handbook of Cannabis and Related Pathologies. Cambridge (MA): Academic Press; 2017. 671–679.
| Volume | 01 |
| Issue | 01 |
| Received | 01/06/2024 |
| Accepted | 18/06/2024 |
| Published | 27/06/2024 |
Login
PlumX Metrics